All eyes on Pfizer as vaccines run short
Unlock all stories free for 10 days
Stay informed on business, government and financial developments across New Zealand.
- Deeply researched, twice-edited and fact-checked news
- Annual subscribers also receive a complimentary subscription to The Wall Street Journal
- Personalised email news alerts, plus gift up to 5 stories a month to non-subscribers
We won’t charge for 10 days. You can cancel anytime with two clicks, an email or a phone call. Find out more.
We are serious about journalism.
You will be charged in 10 days unless you cancel beforehand.
We will remind you three times before charging you.
All subscriptions auto renew but are easy to cancel.
Total Price Including Tax: {{ priceWithTax(selectedPlan) | currency }} {{ selectedPlan.type == 'user' && spark.chargesUsersPerSeat ? '/ '+ spark.seatName : '' }} {{ selectedPlan.type == 'user' && spark.chargesUsersPerTeam ? '/ '+ __('teams.team') : '' }} / {{ __(selectedPlan.interval) | capitalize }}
Or use the information you’ve already given Google to create your subscription.
Not convinced yet?
Subscribe to our free 7am Headlines newsletter.
A quick summary of everything BusinessDesk has published in the previous 24 hours. No BusinessDesk
subscription needed.
NZ not first in line for Aukus, US says Japan the priority
The US has laid out a case for the additional benefits Five Eyes members get from Aukus.
David Chaplin: Float on: why the FMA is stressing about fund liquidity risks
The monetary tide is receding.
Avoiding mistakes many investors make
Managing emotions key to securing long-term returns.
Boosting rural growth with innovation
Productivity and sustainability go hand in hand for the rural sector
